Clinical trial
Benefits and Risks of Newborn Screening for Cystic Fibrosis
NCT00014950 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00014950 |
|---|---|
| Title | Benefits and Risks of Newborn Screening for Cystic Fibrosis |
| Official title | Pulmonary Benefits of Cystic Fibrosis Neonatal Screening |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Lung Disease, Pseudomonas Infections |
| Intervention type | Procedure |
| Interventions | CF newborn screening |
| First posted | Apr 16, 2001 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: